STOCKHOLM — April 16, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has submitted an application to the European Medicines Agency,... read more

Gothenburg, April 15, 2021 – Vicore Pharma Holding AB (publ), a pharmaceutical company developing innovative medicines for severe lung disorders such as idiopathic pulmonary fibrosis (IPF), today announced the publication of the Annual Report 2020. The Annual Report is available on the company... read more

Lund, Sweden, 16:00 CET, 13 April 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, announces that the Annual Report for 2020 is now available as a pdf on the group’s web page, www.bonesupport.com. A pdf version is als... read more

- Mirum expands potential opportunities across rare disease pipeline - Vivet to lead preclinical development of its two gene therapy programs for PFIC3 and PFIC2 - Mirum gains option to license VTX-803 and VTX-802 FOSTER CITY, Calif. and PARIS, France – March 12, 2021 - Mirum Ph... read more

Not for release, publication or distribution, directly or indirectly, in the United States of America, Canada, Japan or Australia THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED BY THE LEGEN... read more